PharmaSGP Holding SE (PSG.DE)
EUR 24.0
(-0.83%)
EUR 24.0
(-0.83%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.11 Million EUR | 44.49% |
| 2022 | 7 Million EUR | 67.31% |
| 2021 | 4.18 Million EUR | 37.85% |
| 2020 | 3.03 Million EUR | 44.85% |
| 2019 | 2.09 Million EUR | -35.86% |
| 2018 | 3.26 Million EUR | 30.3% |
| 2017 | 2.5 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 9.62 Million EUR | -4.57% |
| 2024 Q1 | 10.08 Million EUR | -0.34% |
| 2023 Q4 | 10.11 Million EUR | 4.95% |
| 2023 Q1 | 8.33 Million EUR | 19.04% |
| 2023 Q2 | 9.51 Million EUR | 14.19% |
| 2023 FY | 10.11 Million EUR | 44.49% |
| 2023 Q3 | 9.64 Million EUR | 1.28% |
| 2022 Q3 | 6.31 Million EUR | 5.53% |
| 2022 Q1 | 5.86 Million EUR | 40.22% |
| 2022 FY | 7 Million EUR | 67.31% |
| 2022 Q4 | 7 Million EUR | 10.81% |
| 2022 Q2 | 5.98 Million EUR | 2.04% |
| 2021 Q2 | 3.29 Million EUR | -0.12% |
| 2021 FY | 4.18 Million EUR | 37.85% |
| 2021 Q4 | 4.18 Million EUR | -8.12% |
| 2021 Q3 | 4.55 Million EUR | 38.07% |
| 2021 Q1 | 3.3 Million EUR | 8.79% |
| 2020 Q1 | 2.3 Million EUR | 10.07% |
| 2020 FY | 3.03 Million EUR | 44.85% |
| 2020 Q4 | 3.03 Million EUR | -13.11% |
| 2020 Q3 | 3.49 Million EUR | 37.67% |
| 2020 Q2 | 2.53 Million EUR | 10.01% |
| 2019 FY | 2.09 Million EUR | -35.86% |
| 2019 Q1 | - EUR | 0.0% |
| 2019 Q4 | 2.09 Million EUR | 0.0% |
| 2018 FY | 3.26 Million EUR | 30.3% |
| 2017 FY | 2.5 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| MPH Health Care AG | - EUR | -Infinity% |
| Apontis Pharma AG | 6.6 Million EUR | -53.288% |
| Dermapharm Holding SE | 320.75 Million EUR | 96.846% |
| Evotec SE | 30.89 Million EUR | 67.248% |
| MERCK Kommanditgesellschaft auf Aktien | 4.63 Billion EUR | 99.782% |
| SynBiotic SE | 2.76 Million EUR | -265.948% |